Delayed
Sao Paulo
06:33:19 21/05/2024 pm IST
|
5-day change
|
1st Jan Change
|
59.99
BRL
|
-7.71%
|
|
-0.84%
|
-16.44%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,263
|
3,532
|
4,727
|
9,744
|
8,904
|
7,711
|
Enterprise Value (EV)
1 |
3,430
|
3,694
|
4,327
|
9,597
|
9,294
|
7,635
|
P/E ratio
|
7.12
x
|
23.3
x
|
16.1
x
|
5.94
x
|
6.69
x
|
10.1
x
|
Yield
|
3.99%
|
1.2%
|
-
|
-
|
14%
|
-
|
Capitalization / Revenue
|
0.94
x
|
1.16
x
|
1.22
x
|
1.55
x
|
1.22
x
|
1.57
x
|
EV / Revenue
|
0.99
x
|
1.21
x
|
1.12
x
|
1.53
x
|
1.28
x
|
1.56
x
|
EV / EBITDA
|
3.56
x
|
6.78
x
|
4.55
x
|
3.48
x
|
3.51
x
|
6.2
x
|
EV / FCF
|
12
x
|
19.2
x
|
6.03
x
|
5.47
x
|
13.7
x
|
12.9
x
|
FCF Yield
|
8.34%
|
5.2%
|
16.6%
|
18.3%
|
7.28%
|
7.77%
|
Price to Book
|
2.39
x
|
2.39
x
|
2.8
x
|
4.26
x
|
3.93
x
|
3.27
x
|
Nbr of stocks (in thousands)
|
1,24,168
|
1,19,535
|
1,13,674
|
1,14,227
|
1,13,849
|
1,13,883
|
Reference price
2 |
26.11
|
29.51
|
42.31
|
85.32
|
80.01
|
69.63
|
Announcement Date
|
15/03/19
|
13/03/20
|
17/03/21
|
16/03/22
|
20/03/23
|
14/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
3,469
|
3,049
|
3,868
|
6,289
|
7,270
|
4,897
|
EBITDA
1 |
962.1
|
544.5
|
951.4
|
2,758
|
2,648
|
1,232
|
EBIT
1 |
789.5
|
368.9
|
753.4
|
2,538
|
2,401
|
984.9
|
Operating Margin
|
22.76%
|
12.1%
|
19.48%
|
40.36%
|
33.02%
|
20.11%
|
Earnings before Tax (EBT)
1 |
676.7
|
256.6
|
601.2
|
3,035
|
2,052
|
1,165
|
Net income
1 |
528
|
173.5
|
367.7
|
1,985
|
1,326
|
787.5
|
Net margin
|
15.22%
|
5.69%
|
9.5%
|
31.56%
|
18.24%
|
16.08%
|
EPS
2 |
3.666
|
1.267
|
2.633
|
14.36
|
11.95
|
6.916
|
Free Cash Flow
1 |
286.1
|
192.2
|
718.1
|
1,755
|
676.6
|
593.2
|
FCF margin
|
8.25%
|
6.3%
|
18.57%
|
27.9%
|
9.31%
|
12.11%
|
FCF Conversion (EBITDA)
|
29.74%
|
35.29%
|
75.49%
|
63.63%
|
25.55%
|
48.16%
|
FCF Conversion (Net income)
|
54.18%
|
110.77%
|
195.33%
|
88.4%
|
51.03%
|
75.33%
|
Dividend per Share
2 |
1.043
|
0.3554
|
-
|
-
|
11.19
|
-
|
Announcement Date
|
15/03/19
|
13/03/20
|
17/03/21
|
16/03/22
|
20/03/23
|
14/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
166
|
163
|
-
|
-
|
390
|
-
|
Net Cash position
1 |
-
|
-
|
400
|
148
|
-
|
76.7
|
Leverage (Debt/EBITDA)
|
0.1729
x
|
0.2991
x
|
-
|
-
|
0.1474
x
|
-
|
Free Cash Flow
1 |
286
|
192
|
718
|
1,755
|
677
|
593
|
ROE (net income / shareholders' equity)
|
43.5%
|
11.8%
|
23%
|
98.7%
|
57.1%
|
32.9%
|
ROA (Net income/ Total Assets)
|
13.1%
|
5.94%
|
11.4%
|
29.5%
|
24.5%
|
9.94%
|
Assets
1 |
4,018
|
2,920
|
3,212
|
6,729
|
5,410
|
7,926
|
Book Value Per Share
2 |
10.90
|
12.40
|
15.10
|
20.00
|
20.40
|
21.30
|
Cash Flow per Share
2 |
1.630
|
2.530
|
8.100
|
2.900
|
3.530
|
11.80
|
Capex
1 |
201
|
159
|
132
|
266
|
268
|
412
|
Capex / Sales
|
5.79%
|
5.23%
|
3.42%
|
4.23%
|
3.69%
|
8.42%
|
Announcement Date
|
15/03/19
|
13/03/20
|
17/03/21
|
16/03/22
|
20/03/23
|
14/03/24
|
|
1st Jan change
|
Capi.
|
---|
| +4.67% | 105B | | -5.99% | 62.52B | | +72.86% | 49.08B | | +15.33% | 38.99B | | +5.13% | 32.59B | | +13.81% | 20.6B | | +12.59% | 17.19B | | +18.15% | 15.13B | | +4.83% | 14.36B |
Other Commodity Chemicals
|